Literature DB >> 12181050

Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia.

David P Steensma1, C Christopher Hook, Scott L Stafford, Ayalew Tefferi.   

Abstract

Pulmonary hypertension (PH) can complicate myelofibrosis with myeloid metaplasia (MMM), may arise in the absence of evidence for thromboembolic disease and carries a grim prognosis. Four patients with MMM and severe symptomatic PH were treated with whole-lung external beam radiotherapy in a single fraction of 100 cGy. Within 72 h, each patient noted marked symptomatic improvement and had relief of hypoxia and reduction of oedema and/or ascites. Three of the four patients enjoyed an objective improvement in pulmonary artery systolic pressure as measured by transthoracic Doppler echocardiography. Low-dose lung radiotherapy may be a useful palliative tool for patients with MMM complicated by PH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181050     DOI: 10.1046/j.1365-2141.2002.03695.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantation.

Authors:  Saadia A Faiz; Cezar Iliescu; Juan Lopez-Mattei; Bela Patel; Lara Bashoura; Uday Popat
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms.

Authors:  Emir C Roach; Margaret M Park; W H Wilson Tang; James D Thomas; Kewal Asosingh; Matt Kalaycio; Serpil C Erzurum; Samar Farha
Journal:  J Heart Lung Transplant       Date:  2014-09-28       Impact factor: 10.247

3.  Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

Authors:  Tiziano Barbui; Giovanni Barosi; Gunnar Birgegard; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

Review 4.  The therapy of myelofibrosis: targeting pathogenesis.

Authors:  Ruben A Mesa
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  A Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis.

Authors:  Ceyla Konca Degertekin; Zübeyde Nur Ozkurt; Nalan Akyürek; Münci Yağcı
Journal:  Indian J Hematol Blood Transfus       Date:  2012-12-07       Impact factor: 0.900

6.  Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.

Authors:  Samar Farha; Kewal Asosingh; Weiling Xu; Jacqueline Sharp; Deepa George; Suzy Comhair; Margaret Park; W H Wilson Tang; James E Loyd; Karl Theil; Raymond Tubbs; Eric Hsi; Alan Lichtin; Serpil C Erzurum
Journal:  Blood       Date:  2011-01-21       Impact factor: 22.113

7.  Helical tomotherapy for extramedullary hematopoiesis involving the pericardium in a patient with chronic myeloid leukemia.

Authors:  Daniel R Toms; Leander Cannick; Robert K Stuart; Joseph M Jenrette; Lacy Terwiliger
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

8.  Prevalence of pulmonary hypertension in myelofibrosis.

Authors:  Juan Lopez-Mattei; Srdan Verstovsek; Bryan Fellman; Cezar Iliescu; Karan Bhatti; Saamir A Hassan; Peter Kim; Brian A Gray; Nicolas L Palaskas; Horiana B Grosu; Mamas A Mamas; Saadia A Faiz
Journal:  Ann Hematol       Date:  2020-02-19       Impact factor: 4.030

Review 9.  Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.

Authors:  Roberto F Machado; Harrison W Farber
Journal:  Clin Chest Med       Date:  2013-10-17       Impact factor: 2.878

10.  Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension.

Authors:  Kewal Asosingh; Micheala A Aldred; Amit Vasanji; Judith Drazba; Jacqueline Sharp; Carol Farver; Suzy A A Comhair; Weiling Xu; Lauren Licina; Lan Huang; Bela Anand-Apte; Mervin C Yoder; Rubin M Tuder; Serpil C Erzurum
Journal:  Am J Pathol       Date:  2008-02-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.